Evidence map›Paper›PMID 31639067›Full record

ArticleHuman genomics2019

Robust hypergraph regularized non-negative matrix factorization for sample clustering and feature selection in multi-view gene expression data.

Na Yu, Ying-Lian Gao, Jin-Xing Liu, Juan Wang, Junliang Shang

Abstract read
In one paragraph

Article in Human genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Na YuSchool of Information Science and Engineering, Qufu Normal University, Rizhao, 276826, China.
Ying-Lian GaoLibrary of Qufu Normal University, Qufu Normal University, Rizhao, 276826, China.
Jin-Xing LiuSchool of Information Science and Engineering, Qufu Normal University, Rizhao, 276826, China. sdcavell@126.com.
Juan WangSchool of Information Science and Engineering, Qufu Normal University, Rizhao, 276826, China. wangjuansdu@163.com.
Junliang ShangSchool of Information Science and Engineering, Qufu Normal University, Rizhao, 276826, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs one of the most popular data representation methods, non-negative matrix decomposition (NMF) has been widely concerned in the tasks of clustering and feature selection. However, most of the previously proposed NMF-based methods do not adequately explore the hidden geometrical structure in the data. At the same time, noise and outliers are inevitably present in the data.

resultsTo alleviate these problems, we present a novel NMF framework named robust hypergraph regularized non-negative matrix factorization (RHNMF). In particular, the hypergraph Laplacian regularization is imposed to capture the geometric information of original data. Unlike graph Laplacian regularization which captures the relationship between pairwise sample points, it captures the high-order relationship among more sample points. Moreover, the robustness of the RHNMF is enhanced by using the L

conclusionsClustering and common abnormal expression gene (com-abnormal expression gene) selection are conducted to test the validity of the RHNMF model. Extensive experimental results on multi-view datasets reveal that our proposed model outperforms other state-of-the-art methods.

Indexed as

AlgorithmsDatabases, GeneticGene Expression Regulation, NeoplasticCluster AnalysisHumansNeoplasmsClusteringCommon abnormal gene selectionHypergraph LaplacianL2,1-normMulti-view gene expression dataNon-negative matrix decomposition

Identifiers

PMID31639067
PMCPMC6805321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.